DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 1.75% to $1.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.73% to 51,561.93 and the NASDAQ Composite Index falling 0.09% to 26,830.96.
The stock's rise snapped a three-day losing streak.
Inovio Pharmaceuticals Inc. closed 61.06% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 2.21% to $228.17, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.38% to $25.69.
Trading volume (1.3 M) remained 1.8 million below its 50-day average volume of 3.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 04, 2026 17:25 ET (21:25 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments